The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Potassium Citrate / Sodium Citrate / Citric Acid
Pronunciation: poe-TASS-ee-uhm SIH-trate/SO-dee-uhm SIH-trate/SIH-trik ASS-id
Class: Systemic alkalinizer, Urinary alkalinizer
- Syrup 550 mg potassium citrate, 500 mg sodium citrate, 334 mg citric acid/5 mL (1 mEq K, 1 mEq Na/mL; equiv. to 2 mEq bicarbonate)
- Solution 550 mg potassium citrate, 500 mg sodium citrate, 334 mg citric acid/5 mL (1 mEq K, 1 mEq Na/mL; equiv. to 2 mEq bicarbonate)
Potassium citrate and sodium citrate are metabolized to potassium bicarbonate and sodium bicarbonate, thus acting as systemic alkalizers.
Indications and Usage
Treatment of chronic metabolic acidosis, particularly when caused by renal tubular acidosis; conditions when long-term maintenance of an alkaline urine is desirable, in treatment of patients with uric acid and cystine calculi of the urinary tract and in conjunction with uricosurics in gout therapy to prevent uric acid nephropathy.
Severe renal function impairment with oliguria; azotemia; untreated Addison disease; severe myocardial damage; certain situations when patients are on a sodium- or potassium-restricted diet.
Dosage and AdministrationAdults
PO 3 to 6 tsp (15 to 30 mL), diluted with water, 4 times daily after meals and at bedtime, or as directed by health care provider.Children
PO 1 to 3 tsp (5 to 15 mL), diluted with water 4 times daily after meals and at bedtime, or as directed by health care provider.
Store syrup at controlled room temperature (59° to 86°F). Keep tightly capped and protect from freezing or excessive heat.
Drug InteractionsPotassium-containing medication, potassium-sparing diuretics (eg, spironolactone), ACE inhibitors (eg, captopril), or cardiac glycosides (eg, digoxin)
Concurrent use may lead to toxicity.
Laboratory Test Interactions
None well documented.
Alkalosis; hyperkalemia leading to listlessness, weakness, mental confusion, tingling of extremities, and other symptoms associated with high serum potassium concentrations (eg, ECG abnormalities).
Special Risk Patients
Sodium salts should be used with caution in patients with cardiac failure, hypertension, impaired renal function, peripheral and pulmonary edema, and toxemia of pregnancy.
Low urinary output or reduced glomerular filtration rate
Because hyperkalemia or alkalosis can occur, use with caution.
Dilute with water to minimize GI injury associated with oral ingestion of concentrated potassium salts.
Diarrhea, nausea, vomiting, hypernoia (excessive mental activity), convulsions, hyperkalemia, alkalosis.
- Advise patient to take as prescribed and to not change the dose or stop taking unless advised by health care provider.
- Advise patient to dilute each dose with 1 to 3 oz of cold water and take after meals if possible to prevent laxative effect. Additional water may follow the dose if desired.
- Advise patient that if a dose is missed to take as soon as remembered unless it is nearing time for the next dose. Caution patient to not double the dose to catch up.
- Advise patient to inform health care provider if any of the following occur: edema, decreased urine production, persistent diarrhea, any other bothersome side effects.
Copyright © 2009 Wolters Kluwer Health.